The global safety science leader has signed a definitive agreement to acquire the electrical and electronics testing business of Eurofins Scientific, a French life sciences laboratory group. This strategic transaction represents a definitive portfolio pruning for the seller, marking a structural exit from the technical industrial testing space to concentrate resources on its core bio-analytical segments. The strategic rationale for the move centers on the acquirer's objective to broaden its technical operational depth in the high-growth electronics compliance market while achieving significant geographic densification in North America and Asia. By incorporating this technical specialist, the organization reinforces its ability to serve mission-critical electronics manufacturers requiring high-end certification services. The partnership is designed to leverage the acquirer’s global infrastructure and digital platform to enhance the target’s service delivery and operational efficiency. This integration facilitates the development of a uniquely integrated safety testing platform, providing the strategic depth required to navigate complex international standards and the rising demand for technological safety. The transaction marks the conclusion of the seller’s strategic review of non-core assets, allowing it to refocus capital on automation and artificial intelligence initiatives within its healthcare and environmental laboratories.

MET LABS, which reported an EBITDA margin of LOGIN in 2026, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN premium to the 11.3x average currently observed in the Business Services sector.

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.